Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027
The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022. The growth of the market is mainly attributed to greater adoption of biosensors and connected care devices and higher demand for home-based or home-use products. However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.
“In product segment, blood glucose monitoring systems segment will undergo a significant growth by 2027.”
Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices. The substantial growth of the segment is attributed to the technological advancements and ongoing product approval of continuous glucose monitoring systems, benefits offered by continuous monitoring systems over self-monitoring systems in the market. Continuous glucose monitoring systems offer a wide range of advantages over self-monitoring blood glucose systems, such as non-invasive detection shortened detection time, and reduced cost. These advantages among several other advantages offered by the continuous glucose monitoring systems will lead to the growth of this product segment.
“By end-user hospitals segment is anticipated to account for the major share of the patient monitoring devices market,” `
By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users. The demand growth among hospitals is attributed to the momentous availability of state-of-the-art services for patient treatment, diagnosis, as well as trained personnel, and disease management, that has ensured a stable demand for increasing number of hospitals in major countries and the hospital-based care. More diagnostic and screening procedures are carried out in hospitals, promoting to the increased market share. The influx of patients is usually higher in hospitals as compared to other healthcare settings, which is another key driver for segment growth.
“By Region, Asia Pacific Patient Monitoring Devices Market is anticipated to grow at the highest CAGR by 2027.”
The Asia Pacific market will grow at the highest CAGR during the forecast period majorly due to the rising healthcare expenditure, heavy burden of infectious diseases, and increasing geriatric population along with favourable public and private contribution to overall healthcare infrastructure. Apart from this, the increase in the number of ambulatory surgical centers and development of infrastructure in hospitals the APAC region is expected to propel the patient monitoring devices market.
A breakdown of the primary participants referred to for this report is provided below:
This report studies the patient monitoring devices market based on product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“In product segment, blood glucose monitoring systems segment will undergo a significant growth by 2027.”
Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices. The substantial growth of the segment is attributed to the technological advancements and ongoing product approval of continuous glucose monitoring systems, benefits offered by continuous monitoring systems over self-monitoring systems in the market. Continuous glucose monitoring systems offer a wide range of advantages over self-monitoring blood glucose systems, such as non-invasive detection shortened detection time, and reduced cost. These advantages among several other advantages offered by the continuous glucose monitoring systems will lead to the growth of this product segment.
“By end-user hospitals segment is anticipated to account for the major share of the patient monitoring devices market,” `
By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users. The demand growth among hospitals is attributed to the momentous availability of state-of-the-art services for patient treatment, diagnosis, as well as trained personnel, and disease management, that has ensured a stable demand for increasing number of hospitals in major countries and the hospital-based care. More diagnostic and screening procedures are carried out in hospitals, promoting to the increased market share. The influx of patients is usually higher in hospitals as compared to other healthcare settings, which is another key driver for segment growth.
“By Region, Asia Pacific Patient Monitoring Devices Market is anticipated to grow at the highest CAGR by 2027.”
The Asia Pacific market will grow at the highest CAGR during the forecast period majorly due to the rising healthcare expenditure, heavy burden of infectious diseases, and increasing geriatric population along with favourable public and private contribution to overall healthcare infrastructure. Apart from this, the increase in the number of ambulatory surgical centers and development of infrastructure in hospitals the APAC region is expected to propel the patient monitoring devices market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
- By Designation: C-level–47%, Director-level–33%, and Others–20%
- By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%
- Abbott Laboratories (US),
- HILL-ROM HOLDINGS, INC. (US),
- Dr?gerwerk AG & Co. KGaA (Germany),
- Edwards Lifesciences Corporation (US),
- OMRON Corporation (Japan),
- Masimo Corporation (US),
- Compumedics Limited (Australia),
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China),
- Nihon Kohden Corporation (Japan),
- Natus Medical (US), Medtronic plc (Ireland),
- Koninklijke Philips N.V. (Netherlands),
- GE Healthcare (US), Getinge AB (Sweden),
- Boston Scientific Corporation (US),
- Dexcom, Inc. (US),
- Nonin (US),
- BIOTRONIK (Germany),
- SCHILLER (Switzerland),
- BioTelemetry, Inc. (US)
This report studies the patient monitoring devices market based on product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient monitoring devices market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the patient monitoring devices market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient monitoring devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 PATIENT MONITORING DEVICES MARKET
FIGURE 2 PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 3 PATIENT MONITORING DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS
3 EXECUTIVE SUMMARY
FIGURE 10 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 PATIENT MONITORING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 PATIENT MONITORING DEVICES MARKET OVERVIEW
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS AND RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR PATIENT MONITORING DEVICES
4.2 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY & PRODUCT
FIGURE 14 JAPAN HOLDS LARGEST HIGHEST SHARE OF APAC MARKET
4.3 PATIENT MONITORING DEVICES MARKET SHARE, BY END USER
FIGURE 15 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING 2022–2027
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST RATE DURING 2022–2027
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing technological advancements and innovations
5.2.1.1.1 Increased user-centric designs for wearable devices
5.2.1.1.2 Growing use of non-invasive hemodynamic monitoring
5.2.1.1.3 Rising use of digital data sensors
5.2.1.1.4 Growing use of mobile-grade EEG devices
5.2.1.2 Rising prevalence of chronic diseases
5.2.1.3 Availability of wireless monitoring devices
TABLE 3 RECENT PRODUCT INNOVATIONS IN PATIENT MONITORING DEVICES MARKET
5.2.1.4 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
5.2.1.5 Growing investments, funds, and grants in healthcare systems
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with invasive monitoring devices
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled healthcare professionals
5.2.4.2 Increased pricing pressure on market players
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 ECOSYSTEM ANALYSIS
5.5 REGULATORY ANALYSIS
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.5.2 EUROPE
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)
TABLE 10 EXPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 11 DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
6 PATIENT MONITORING DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 12 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BLOOD GLUCOSE MONITORING SYSTEMS
TABLE 13 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
6.2.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.2.1.1 Rising adoption of integrated glucose monitoring systems to drive growth
TABLE 16 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring systems to drive market growth
TABLE 17 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 CARDIAC MONITORING DEVICES
TABLE 18 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 20 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.3.1 ECG DEVICES
6.3.1.1 Low cost and wide applications of ECG devices to drive market growth
TABLE 21 ECG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 IMPLANTABLE LOOP RECORDERS
6.3.2.1 High cost and limited applications limit growth
TABLE 22 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.3 EVENT MONITORS
6.3.3.1 Emergence of portable and wireless event monitors to drive market growth
TABLE 23 EVENT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.4 MCT MONITORS
6.3.4.1 Availability of alternate technologies likely to hinder market growth
TABLE 24 MCT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.5 SMART/WEARABLE ECG MONITORS
6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
TABLE 25 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
TABLE 26 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 MULTI-PARAMETER MONITORING DEVICES
TABLE 27 MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.4.1 LOW-ACUITY MONITORING DEVICES
6.4.1.1 Increasing adoption of low-acuity monitoring devices to improve care in general wards drives market growth
TABLE 30 LOW-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.2 MID-ACUITY MONITORING DEVICES
6.4.2.1 Rising geriatric population is likely to increase market growth
TABLE 31 MID-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.3 HIGH-ACUITY MONITORING DEVICES
6.4.3.1 Increasing partnerships between manufacturers and hospitals drive device sales
TABLE 32 HIGH-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 RESPIRATORY MONITORING DEVICES
TABLE 33 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 35 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.5.1 PULSE OXIMETERS
6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
TABLE 36 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.2 SPIROMETERS
6.5.2.1 Technological advancements to increase the adoption of spirometers
TABLE 37 SPIROMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.3 CAPNOGRAPHS
6.5.3.1 Product development and growing commercial acceptance to drive market growth
TABLE 38 CAPNOGRAPHS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.4 PEAK FLOW METERS
6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices hinders market growth
TABLE 39 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 TEMPERATURE MONITORING DEVICES
TABLE 40 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 42 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
TABLE 43 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 44 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
TABLE 45 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
TABLE 46 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 47 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
6.6.4.1 Risk of bloodstream infections associated with catheter usage hinders market for invasive devices
TABLE 48 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.5 SMART TEMPERATURE MONITORING PATCHES
6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
TABLE 49 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
TABLE 50 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
TABLE 51 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 53 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.7.1 HEMODYNAMIC MONITORS
6.7.1.1 Influx of VC funding to drive market growth
TABLE 54 HEMODYNAMIC MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.2 BLOOD PRESSURE MONITORS
6.7.2.1 Development of wearable blood pressure monitors to drive market growth
TABLE 55 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
TABLE 56 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.3 DISPOSABLES
6.7.3.1 Growing number of surgical procedures to drive growth in disposables market
TABLE 57 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 FETAL & NEONATAL MONITORING DEVICES
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.8.1 FETAL MONITORING DEVICES
6.8.1.1 Rising prevalence of obstetric complications, growing pre-term birth rate drive market growth
TABLE 61 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
TABLE 62 FETAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.2 NEONATAL MONITORING DEVICES
6.8.2.1 Rising number of neonatal care facilities worldwide to drive market
TABLE 63 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 NEUROMONITORING DEVICES
TABLE 64 NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 NEUROMONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 NEUROMONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.9.1 EEG MACHINES
6.9.1.1 Growing applications and technological advancements form key market growth drivers
TABLE 67 EEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.2 EMG MACHINES
6.9.2.1 Availability of reimbursements for EMG-assisted surgeries boosts product demand
TABLE 68 EMG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.3 CEREBRAL OXIMETERS
6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
TABLE 69 CEREBRAL OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.4 ICP MONITORS
6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs support adoption of ICP monitors
TABLE 70 ICP MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.5 MEG MACHINES
6.9.5.1 High implementation and maintenance costs of MEG devices likely to hinder market growth
TABLE 71 MEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.6 TCD MACHINES
6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth
TABLE 72 TCD MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.10 WEIGHT MONITORING DEVICES
TABLE 73 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 75 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.10.1 DIGITAL WEIGHT MONITORING DEVICES
6.10.1.1 Consumer preference for digital scales—a key market driver
TABLE 76 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.10.2 ANALOG WEIGHT MONITORING DEVICES
6.10.2.1 Rising prevalence of obesity and low cost of analog scales support market growth
TABLE 77 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.11 OTHER PATIENT MONITORING DEVICES
TABLE 78 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
TABLE 79 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 80 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 81 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
7 PATIENT MONITORING DEVICES MARKET, BY END USER
7.1 INTRODUCTION
TABLE 82 PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
7.2 HOSPITALS
7.2.1 HOSPITALS TO DOMINATE END-USER MARKET
TABLE 83 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
7.3 AMBULATORY SURGERY CENTERS
7.3.1 COST-EFFECTIVENESS AND CONVENIENCE DRIVE DEMAND FOR AMBULATORY CARE
TABLE 84 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)
7.4 HOME CARE SETTINGS
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
TABLE 85 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
7.5 OTHER END USERS
TABLE 86 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
8 PATIENT MONITORING DEVICES MARKET, BY REGION
8.1 INTRODUCTION
TABLE 87 PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.1 US
8.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth
TABLE 100 VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US
TABLE 101 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2.2 CANADA
8.2.2.1 Growing public-private funding for research to drive market growth
TABLE 111 RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA
TABLE 112 RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET
TABLE 113 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3 EUROPE
TABLE 123 PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET
TABLE 124 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 125 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 126 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3.1 GERMANY
8.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
TABLE 136 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.2 UK
8.3.2.1 Increasing public & private investments contribute to market growth
TABLE 146 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.3 FRANCE
8.3.3.1 Statutory health insurance system to support market growth
TABLE 156 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 157 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.4 ITALY
8.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
TABLE 166 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.5 SPAIN
8.3.5.1 Growing number of surgical procedures to drive market growth in Spain
TABLE 176 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 177 SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.6 REST OF EUROPE
TABLE 186 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE
TABLE 187 ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 ROE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 ROE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT
TABLE 197 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 198 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 199 ASIA PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 ASIA PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.1 JAPAN
8.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
TABLE 209 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN JAPAN
TABLE 210 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 211 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 JAPAN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.2 CHINA
8.4.2.1 Growing focus of local and international market players on this market
TABLE 220 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN CHINA
TABLE 221 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 222 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 223 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 CHINA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 225 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 230 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.3 INDIA
8.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
TABLE 231 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 232 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 233 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 INDIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 239 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 240 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.4 AUSTRALIA
8.4.4.1 R&D Tax Incentive Program to support market growth
TABLE 241 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 242 AUSTRALIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 243 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 AUSTRALIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 245 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 249 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 250 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.5 SOUTH KOREA
8.4.5.1 Supportive government initiatives to drive market growth
TABLE 251 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 252 SOUTH KOREA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 253 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 254 SOUTH KOREA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 256 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 257 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 258 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 260 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.6 REST OF ASIA PACIFIC
TABLE 261 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN ROAPAC
TABLE 262 ROAPAC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 263 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 265 ROAPAC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 266 ROAPAC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 ROAPAC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 ROAPAC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 ROAPAC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 270 ROAPAC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 ROAPAC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
TABLE 272 LATAM: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 273 LATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 274 LATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 LATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 LATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 LATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 LATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 279 LATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 280 LATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 281 LATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 LATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 283 LATAM: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.5.1 BRAZIL
8.5.1.1 Brazil to dominate LATAM market
TABLE 284 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 285 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 286 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 287 BRAZIL: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 288 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 292 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 293 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.2 MEXICO
8.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 294 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 295 MEXICO: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 296 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 297 MEXICO: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 302 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.3 REST OF LATIN AMERICA
TABLE 304 ROLATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 305 ROLATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 306 ROLATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 307 ROLATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 ROLATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 ROLATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 ROLATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 ROLATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 312 ROLATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 ROLATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST & AFRICA
8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN THE REGION
TABLE 314 MEA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 315 MEA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 316 MEA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 317 MEA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 318 MEA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 MEA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 320 MEA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 321 MEA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 MEA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 323 MEA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 324 MEA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT MONITORING DEVICES MARKET
9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET
9.4 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
TABLE 325 OVERALL COMPANY FOOTPRINT
TABLE 326 COMPANY PRODUCT FOOTPRINT
TABLE 327 COMPANY END-USER FOOTPRINT
TABLE 328 COMPANY REGIONAL FOOTPRINT
9.5 COMPANY EVALUATION QUADRANT
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
FIGURE 24 PATIENT MONITORING DEVICES: COMPETITIVE LEADERSHIP MAPPING (2021)
9.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
9.6.1 PROGRESSIVE COMPANIES
9.6.2 DYNAMIC COMPANIES
9.6.3 STARTING BLOCKS
9.6.4 RESPONSIVE COMPANIES
FIGURE 25 PATIENT MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUP COMPANIES (2021)
9.7 KEY STAKEHOLDERS AND BUYING CRITERIA
9.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES
TABLE 329 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES
9.7.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
TABLE 330 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
9.8 MARKET RANKING ANALYSIS
FIGURE 28 LEADING PLAYERS IN PATIENT MONITORING DEVICES MARKET (2021)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 331 PRODUCT LAUNCHES & APPROVALS, 2020–2022
9.9.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 332 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2020
9.9.3 MERGERS & ACQUISITIONS
TABLE 333 MERGERS & ACQUISITIONS, 2017–2020
9.9.4 EXPANSIONS
TABLE 334 EXPANSIONS, 2017–2020
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 GE HEALTHCARE
TABLE 335 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
10.1.2 MEDTRONIC PLC
TABLE 336 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
10.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 337 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
FIGURE 31 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2021)
10.1.4 ABBOTT LABORATORIES
TABLE 338 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
10.1.5 NIHON KOHDEN CORPORATION
TABLE 339 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
FIGURE 33 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2021)
10.1.6 MASIMO CORPORATION
TABLE 340 MASIMO CORPORATION: COMPANY OVERVIEW
FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.7 OMRON CORPORATION
TABLE 341 OMRON CORPORATION: COMPANY OVERVIEW
FIGURE 35 OMRON CORPORATION: COMPANY SNAPSHOT (2021)
10.1.8 EDWARDS LIFESCIENCES CORPORATION
TABLE 342 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 36 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021)
10.1.9 HILL-ROM HOLDINGS
TABLE 343 HILL-ROM HOLDINGS: COMPANY OVERVIEW
FIGURE 37 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
10.1.10 DR?GERWERK AG & CO. KGAA
TABLE 344 DR?GERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 38 DR?GERWERK: COMPANY SNAPSHOT (2021)
10.1.11 NATUS MEDICAL
TABLE 345 NATUS MEDICAL: COMPANY OVERVIEW
FIGURE 39 NATUS MEDICAL: COMPANY SNAPSHOT (2021)
10.1.12 GETINGE AB
TABLE 346 GETINGE AB: COMPANY OVERVIEW
FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2021)
10.1.13 COMPUMEDICS LIMITED
TABLE 347 COMPUMEDICS LIMITED: COMPANY OVERVIEW
FIGURE 41 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2021)
10.1.14 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
TABLE 348 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: COMPANY OVERVIEW
10.1.15 NONIN
TABLE 349 NONIN: COMPANY OVERVIEW
10.1.16 RECENT DEVELOPMENTS
10.2 OTHER COMPANIES
10.2.1 BIOTRONIK
10.2.2 BOSTON SCIENTIFIC CORPORATION
10.2.3 BIOTELEMETRY
10.2.4 SCHILLER
10.2.5 DEXCOM
10.2.6 SENSEONICS
10.2.7 CARDIOMO
10.2.8 VITLS
10.2.9 NETEERA
10.2.10 TYTO CARE
10.2.11 QARDIO
10.2.12 EJENTA
10.2.13 VIVIFY HEALTH
10.2.14 NOTEWORTH
10.2.15 IRHYTHM TECHNOLOGIES, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 PATIENT MONITORING DEVICES MARKET
FIGURE 2 PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 3 PATIENT MONITORING DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS
3 EXECUTIVE SUMMARY
FIGURE 10 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 PATIENT MONITORING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 PATIENT MONITORING DEVICES MARKET OVERVIEW
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS AND RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR PATIENT MONITORING DEVICES
4.2 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY & PRODUCT
FIGURE 14 JAPAN HOLDS LARGEST HIGHEST SHARE OF APAC MARKET
4.3 PATIENT MONITORING DEVICES MARKET SHARE, BY END USER
FIGURE 15 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING 2022–2027
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST RATE DURING 2022–2027
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing technological advancements and innovations
5.2.1.1.1 Increased user-centric designs for wearable devices
5.2.1.1.2 Growing use of non-invasive hemodynamic monitoring
5.2.1.1.3 Rising use of digital data sensors
5.2.1.1.4 Growing use of mobile-grade EEG devices
5.2.1.2 Rising prevalence of chronic diseases
5.2.1.3 Availability of wireless monitoring devices
TABLE 3 RECENT PRODUCT INNOVATIONS IN PATIENT MONITORING DEVICES MARKET
5.2.1.4 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
5.2.1.5 Growing investments, funds, and grants in healthcare systems
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with invasive monitoring devices
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled healthcare professionals
5.2.4.2 Increased pricing pressure on market players
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 ECOSYSTEM ANALYSIS
5.5 REGULATORY ANALYSIS
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.5.2 EUROPE
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)
TABLE 10 EXPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 11 DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
6 PATIENT MONITORING DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 12 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BLOOD GLUCOSE MONITORING SYSTEMS
TABLE 13 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
6.2.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.2.1.1 Rising adoption of integrated glucose monitoring systems to drive growth
TABLE 16 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring systems to drive market growth
TABLE 17 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 CARDIAC MONITORING DEVICES
TABLE 18 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 20 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.3.1 ECG DEVICES
6.3.1.1 Low cost and wide applications of ECG devices to drive market growth
TABLE 21 ECG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 IMPLANTABLE LOOP RECORDERS
6.3.2.1 High cost and limited applications limit growth
TABLE 22 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.3 EVENT MONITORS
6.3.3.1 Emergence of portable and wireless event monitors to drive market growth
TABLE 23 EVENT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.4 MCT MONITORS
6.3.4.1 Availability of alternate technologies likely to hinder market growth
TABLE 24 MCT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.5 SMART/WEARABLE ECG MONITORS
6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
TABLE 25 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
TABLE 26 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 MULTI-PARAMETER MONITORING DEVICES
TABLE 27 MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.4.1 LOW-ACUITY MONITORING DEVICES
6.4.1.1 Increasing adoption of low-acuity monitoring devices to improve care in general wards drives market growth
TABLE 30 LOW-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.2 MID-ACUITY MONITORING DEVICES
6.4.2.1 Rising geriatric population is likely to increase market growth
TABLE 31 MID-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4.3 HIGH-ACUITY MONITORING DEVICES
6.4.3.1 Increasing partnerships between manufacturers and hospitals drive device sales
TABLE 32 HIGH-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 RESPIRATORY MONITORING DEVICES
TABLE 33 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 35 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.5.1 PULSE OXIMETERS
6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
TABLE 36 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.2 SPIROMETERS
6.5.2.1 Technological advancements to increase the adoption of spirometers
TABLE 37 SPIROMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.3 CAPNOGRAPHS
6.5.3.1 Product development and growing commercial acceptance to drive market growth
TABLE 38 CAPNOGRAPHS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5.4 PEAK FLOW METERS
6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices hinders market growth
TABLE 39 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 TEMPERATURE MONITORING DEVICES
TABLE 40 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 42 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
TABLE 43 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 44 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
TABLE 45 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
TABLE 46 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 47 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
6.6.4.1 Risk of bloodstream infections associated with catheter usage hinders market for invasive devices
TABLE 48 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.5 SMART TEMPERATURE MONITORING PATCHES
6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
TABLE 49 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
TABLE 50 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
TABLE 51 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 53 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.7.1 HEMODYNAMIC MONITORS
6.7.1.1 Influx of VC funding to drive market growth
TABLE 54 HEMODYNAMIC MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.2 BLOOD PRESSURE MONITORS
6.7.2.1 Development of wearable blood pressure monitors to drive market growth
TABLE 55 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
TABLE 56 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7.3 DISPOSABLES
6.7.3.1 Growing number of surgical procedures to drive growth in disposables market
TABLE 57 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 FETAL & NEONATAL MONITORING DEVICES
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.8.1 FETAL MONITORING DEVICES
6.8.1.1 Rising prevalence of obstetric complications, growing pre-term birth rate drive market growth
TABLE 61 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
TABLE 62 FETAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.2 NEONATAL MONITORING DEVICES
6.8.2.1 Rising number of neonatal care facilities worldwide to drive market
TABLE 63 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 NEUROMONITORING DEVICES
TABLE 64 NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 NEUROMONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 NEUROMONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.9.1 EEG MACHINES
6.9.1.1 Growing applications and technological advancements form key market growth drivers
TABLE 67 EEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.2 EMG MACHINES
6.9.2.1 Availability of reimbursements for EMG-assisted surgeries boosts product demand
TABLE 68 EMG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.3 CEREBRAL OXIMETERS
6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
TABLE 69 CEREBRAL OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.4 ICP MONITORS
6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs support adoption of ICP monitors
TABLE 70 ICP MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.5 MEG MACHINES
6.9.5.1 High implementation and maintenance costs of MEG devices likely to hinder market growth
TABLE 71 MEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9.6 TCD MACHINES
6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth
TABLE 72 TCD MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.10 WEIGHT MONITORING DEVICES
TABLE 73 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 75 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
6.10.1 DIGITAL WEIGHT MONITORING DEVICES
6.10.1.1 Consumer preference for digital scales—a key market driver
TABLE 76 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.10.2 ANALOG WEIGHT MONITORING DEVICES
6.10.2.1 Rising prevalence of obesity and low cost of analog scales support market growth
TABLE 77 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.11 OTHER PATIENT MONITORING DEVICES
TABLE 78 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
TABLE 79 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 80 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 81 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
7 PATIENT MONITORING DEVICES MARKET, BY END USER
7.1 INTRODUCTION
TABLE 82 PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
7.2 HOSPITALS
7.2.1 HOSPITALS TO DOMINATE END-USER MARKET
TABLE 83 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
7.3 AMBULATORY SURGERY CENTERS
7.3.1 COST-EFFECTIVENESS AND CONVENIENCE DRIVE DEMAND FOR AMBULATORY CARE
TABLE 84 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)
7.4 HOME CARE SETTINGS
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
TABLE 85 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
7.5 OTHER END USERS
TABLE 86 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
8 PATIENT MONITORING DEVICES MARKET, BY REGION
8.1 INTRODUCTION
TABLE 87 PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 89 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.1 US
8.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth
TABLE 100 VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US
TABLE 101 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2.2 CANADA
8.2.2.1 Growing public-private funding for research to drive market growth
TABLE 111 RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA
TABLE 112 RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET
TABLE 113 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3 EUROPE
TABLE 123 PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET
TABLE 124 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 125 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 126 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3.1 GERMANY
8.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
TABLE 136 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.2 UK
8.3.2.1 Increasing public & private investments contribute to market growth
TABLE 146 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.3 FRANCE
8.3.3.1 Statutory health insurance system to support market growth
TABLE 156 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 157 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.4 ITALY
8.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
TABLE 166 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.5 SPAIN
8.3.5.1 Growing number of surgical procedures to drive market growth in Spain
TABLE 176 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 177 SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.3.6 REST OF EUROPE
TABLE 186 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE
TABLE 187 ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 ROE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 ROE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT
TABLE 197 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 198 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 199 ASIA PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 ASIA PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.1 JAPAN
8.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
TABLE 209 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN JAPAN
TABLE 210 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 211 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 JAPAN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 216 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.2 CHINA
8.4.2.1 Growing focus of local and international market players on this market
TABLE 220 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN CHINA
TABLE 221 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 222 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 223 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 CHINA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 225 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 226 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 227 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 230 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.3 INDIA
8.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
TABLE 231 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 232 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 233 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 234 INDIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 235 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 236 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 239 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 240 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.4 AUSTRALIA
8.4.4.1 R&D Tax Incentive Program to support market growth
TABLE 241 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 242 AUSTRALIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 243 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 AUSTRALIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 245 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 248 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 249 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 250 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.5 SOUTH KOREA
8.4.5.1 Supportive government initiatives to drive market growth
TABLE 251 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 252 SOUTH KOREA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 253 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 254 SOUTH KOREA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 256 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 257 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 258 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 259 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 260 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.4.6 REST OF ASIA PACIFIC
TABLE 261 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN ROAPAC
TABLE 262 ROAPAC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 263 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 265 ROAPAC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 266 ROAPAC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 ROAPAC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 268 ROAPAC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 ROAPAC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 270 ROAPAC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 271 ROAPAC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
TABLE 272 LATAM: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 273 LATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 274 LATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 275 LATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 276 LATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 LATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 278 LATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 279 LATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 280 LATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 281 LATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 LATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 283 LATAM: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.5.1 BRAZIL
8.5.1.1 Brazil to dominate LATAM market
TABLE 284 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 285 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 286 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 287 BRAZIL: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 288 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 291 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 292 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 293 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.2 MEXICO
8.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 294 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 295 MEXICO: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 296 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 297 MEXICO: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 299 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 300 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 301 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 302 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.5.3 REST OF LATIN AMERICA
TABLE 304 ROLATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 305 ROLATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 306 ROLATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 307 ROLATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 308 ROLATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 309 ROLATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 310 ROLATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 311 ROLATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 312 ROLATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 ROLATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST & AFRICA
8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN THE REGION
TABLE 314 MEA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 315 MEA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 316 MEA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 317 MEA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 318 MEA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 319 MEA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 320 MEA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 321 MEA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 MEA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 323 MEA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 324 MEA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT MONITORING DEVICES MARKET
9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET
9.4 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
TABLE 325 OVERALL COMPANY FOOTPRINT
TABLE 326 COMPANY PRODUCT FOOTPRINT
TABLE 327 COMPANY END-USER FOOTPRINT
TABLE 328 COMPANY REGIONAL FOOTPRINT
9.5 COMPANY EVALUATION QUADRANT
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
FIGURE 24 PATIENT MONITORING DEVICES: COMPETITIVE LEADERSHIP MAPPING (2021)
9.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
9.6.1 PROGRESSIVE COMPANIES
9.6.2 DYNAMIC COMPANIES
9.6.3 STARTING BLOCKS
9.6.4 RESPONSIVE COMPANIES
FIGURE 25 PATIENT MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUP COMPANIES (2021)
9.7 KEY STAKEHOLDERS AND BUYING CRITERIA
9.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES
TABLE 329 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES
9.7.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
TABLE 330 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
9.8 MARKET RANKING ANALYSIS
FIGURE 28 LEADING PLAYERS IN PATIENT MONITORING DEVICES MARKET (2021)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 331 PRODUCT LAUNCHES & APPROVALS, 2020–2022
9.9.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 332 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2020
9.9.3 MERGERS & ACQUISITIONS
TABLE 333 MERGERS & ACQUISITIONS, 2017–2020
9.9.4 EXPANSIONS
TABLE 334 EXPANSIONS, 2017–2020
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 GE HEALTHCARE
TABLE 335 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
10.1.2 MEDTRONIC PLC
TABLE 336 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
10.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 337 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
FIGURE 31 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2021)
10.1.4 ABBOTT LABORATORIES
TABLE 338 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
10.1.5 NIHON KOHDEN CORPORATION
TABLE 339 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
FIGURE 33 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2021)
10.1.6 MASIMO CORPORATION
TABLE 340 MASIMO CORPORATION: COMPANY OVERVIEW
FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.7 OMRON CORPORATION
TABLE 341 OMRON CORPORATION: COMPANY OVERVIEW
FIGURE 35 OMRON CORPORATION: COMPANY SNAPSHOT (2021)
10.1.8 EDWARDS LIFESCIENCES CORPORATION
TABLE 342 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 36 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021)
10.1.9 HILL-ROM HOLDINGS
TABLE 343 HILL-ROM HOLDINGS: COMPANY OVERVIEW
FIGURE 37 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
10.1.10 DR?GERWERK AG & CO. KGAA
TABLE 344 DR?GERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 38 DR?GERWERK: COMPANY SNAPSHOT (2021)
10.1.11 NATUS MEDICAL
TABLE 345 NATUS MEDICAL: COMPANY OVERVIEW
FIGURE 39 NATUS MEDICAL: COMPANY SNAPSHOT (2021)
10.1.12 GETINGE AB
TABLE 346 GETINGE AB: COMPANY OVERVIEW
FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2021)
10.1.13 COMPUMEDICS LIMITED
TABLE 347 COMPUMEDICS LIMITED: COMPANY OVERVIEW
FIGURE 41 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2021)
10.1.14 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
TABLE 348 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: COMPANY OVERVIEW
10.1.15 NONIN
TABLE 349 NONIN: COMPANY OVERVIEW
10.1.16 RECENT DEVELOPMENTS
10.2 OTHER COMPANIES
10.2.1 BIOTRONIK
10.2.2 BOSTON SCIENTIFIC CORPORATION
10.2.3 BIOTELEMETRY
10.2.4 SCHILLER
10.2.5 DEXCOM
10.2.6 SENSEONICS
10.2.7 CARDIOMO
10.2.8 VITLS
10.2.9 NETEERA
10.2.10 TYTO CARE
10.2.11 QARDIO
10.2.12 EJENTA
10.2.13 VIVIFY HEALTH
10.2.14 NOTEWORTH
10.2.15 IRHYTHM TECHNOLOGIES, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
